Comparative effectiveness of first-line anti-PD-1 versus cetuximab in advanced cutaneous squamous cell carcinoma: A nationwide population-based study using the French national health data system
European Journal of Cancer · 2026
DOI: 10.1016/j.ejca.2026.116585 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift European Journal of Cancer, 2026. Verfasst von Quentin Samaran und 2 weiteren Autor:innen. Beteiligte Einrichtung: Epidemiology in Dermatology and Evaluation of Therapeutics (EpiDermE) EA7379, University Paris-Est Créteil Val de Marne, Créteil, France; Department …. Hauptthemen laut MEDLINE: Cetuximab, Cutaneous Squamous Cell Carcinoma, Skin Neoplasms, Immune Checkpoint Inhibitors. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CHU de Montpellier.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Epidemiology in Dermatology and Evaluation of Therapeutics (EpiDermE) EA7379, University Paris-Est Créteil Val de Marne, Créteil, France; Department of Dermatology, Montpellier University Hospital, Montpellier, France;…
- Epidemiology in Dermatology and Evaluation of Therapeutics (EpiDermE) EA7379, University Paris-Est Créteil Val de Marne, Créteil, France; Department of Dermatology, Henri Mondor Hospital, Créteil, France.
- Epidemiology in Dermatology and Evaluation of Therapeutics (EpiDermE) EA7379, University Paris-Est Créteil Val de Marne, Créteil, France; Department of Dermatology, Henri Mondor Hospital, Créteil, France; Clinical Inves…
Förderung
- CHU de Montpellier
Zitieren
APA
Samaran, Q., Bettuzzi, T., & Sbidian, E. (2026). Comparative effectiveness of first-line anti-PD-1 versus cetuximab in advanced cutaneous squamous cell carcinoma: A nationwide population-based study using the French national health data system. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2026.116585
Vancouver
Samaran Q, Bettuzzi T, Sbidian E. Comparative effectiveness of first-line anti-PD-1 versus cetuximab in advanced cutaneous squamous cell carcinoma: A nationwide population-based study using the French national health data system. European Journal of Cancer. 2026. doi:10.1016/j.ejca.2026.116585
BibTeX
@article{Samaran2026,
author = {Samaran, Quentin and Bettuzzi, Thomas and Sbidian, Emilie},
title = {Comparative effectiveness of first-line anti-PD-1 versus cetuximab in advanced cutaneous squamous cell carcinoma: A nationwide population-based study using the French national health data system},
journal = {European Journal of Cancer},
year = {2026},
doi = {10.1016/j.ejca.2026.116585}
}
EUVIMED